Wilma E. Mesker

7.6k citations
160 papers · 5.6k · h-index 40

Impact in

  • Oncology top 1%
    • Cancer Cells and Metastasis
    • Colorectal Cancer Surgical Treatments
  • Cancer Research top 1%
    • Breast Cancer Treatment Studies

Papers in

  • Oncology 54
    • Colorectal Cancer Surgical Treatments 18
    • Colorectal Cancer Treatments and Studies 11
    • Colorectal Cancer Screening and Detection 10
  • Molecular Biology 48
    • Glycosylation and Glycoproteins Research 19
Co-authors
Rob A.�E.�M. Tollenaar (100 shared papers)Gabi W. van Pelt (39 shared papers)Hans J. Tanke (31 shared papers)Vincent T.H.B.M. Smit (17 shared papers)Peter J.K. Kuppen (17 shared papers)Tim Dekker (17 shared papers)Cornelis J.�H. van de Velde (12 shared papers)Manfred Wuhrer (18 shared papers)
Journals
Breast Cancer Research and Treatment (10 papers)Cytometry (8 papers)Annals of Oncology (6 papers)Cellular Oncology (6 papers)International Journal of Cancer (6 papers)
Partner nations
NetherlandsUnited StatesUnited Kingdom

In The Last Decade

Wilma E. Mesker

153 papers receiving 5.5k citations

Peers

Wilma E. Mesker
Comparison fields: 5 of 127
  • Oncology 1.9k
  • Cancer Research 1.0k
  • Molecular Biology 2.0k
  • Pathology and Forensic Medicine 428
  • Radiology, Nuclear Medicine and Imaging 545
Replace Katja Specht with:
Katja Specht Germany
Arne Warth Germany
Gustavo Baretton Germany
Mark C. Kelley United States
Vincent T.H.B.M. Smit Netherlands
Silvia Darb‐Esfahani Germany
Nam Hoon Cho South Korea
Elaine W. Kay Ireland
Maarit Bärlund Finland
Raheela Ashfaq United States
Wilma E. Mesker relative to Katja Specht Germany Katja Specht's profile →
Citations per field
00.5×2×3.0×
Katja Specht · 1×
Citations per year

Countries citing papers authored by Wilma E. Mesker

Since Specialization
Citations

This map shows the geographic impact of Wilma E. Mesker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilma E. Mesker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilma E. Mesker more than expected).

Fields of papers citing papers by Wilma E. Mesker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilma E. Mesker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilma E. Mesker. The network helps show where Wilma E. Mesker may publish in the future.

Co-authors

The 25 scholars most cited alongside Wilma E. Mesker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wilma E. Mesker Line = papers co-authored together Wilma E. Mesker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage
Analytical Cellular Pathology ·Wilma E. Mesker, Jan M. C. Junggeburt, Károly Szuhai, Pieter de Heer, Hans Morreau, Hans J. Tanke, Rob A.�E.�M. Tollenaar
2007289
2
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
Annals of Oncology ·A. Huijbers, Rob A.�E.�M. Tollenaar, Gabi W. van Pelt, Eliane C.M. Zeestraten, Susan Dutton, Christopher C. McConkey, Enric Domingo, Vincent T.H.B.M. Smit, Rachel Midgley, B F Warren, Elaine Johnstone, David Kerr, Wilma E. Mesker
2012257
3
Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
Breast Cancer Research and Treatment ·Esther M. de Kruijf, Johanna G. H. van Nes, Cornelis J.�H. van de Velde, Hein Putter, Vincent T.H.B.M. Smit, Gerrit‐Jan Liefers, Peter J.K. Kuppen, Rob A.�E.�M. Tollenaar, Wilma E. Mesker
2010242
4
Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts
Oncogene ·Lukas J.A.C. Hawinkels, Madelon Paauwe, Hein W. Verspaget, Eliza Wiercinska, J. M. Van Der Zon, Kattria van der Ploeg, Pim J. Koelink, J. Lindeman, Wilma E. Mesker, Peter ten Dijke, Cornelis F.M. Sier
2012219
5
TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis
Molecular Cell ·Long Zhang, Fangfang Zhou, Amaya García de Vinuesa, Esther M. de Kruijf, Wilma E. Mesker, Hui Li, Yvette Drabsch, Yihao Li, Andreas Bauer, Adrien Rousseau, Kelly-Ann Sheppard, Craig Mickanin, Peter J.K. Kuppen, Chuang Lu, Peter ten Dijke
2013197
6
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
Nature Communications ·Fangfang Zhou, Yvette Drabsch, Tim Dekker, Amaya García de Vinuesa, Yihao Li, Lukas J.A.C. Hawinkels, Kelly-Ann Sheppard, Marie‐José Goumans, Rodney B. Luwor, Carlie J.M. de Vries, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, Peter Devilee, Chuang Lu, Hong‐Jian Zhu, Long Zhang, Peter ten Dijke
2014162
7
Linkage-Specific in Situ Sialic Acid Derivatization for N-Glycan Mass Spectrometry Imaging of Formalin-Fixed Paraffin-Embedded Tissues
Analytical Chemistry ·Stephanie Holst, Bram Heijs, Noortje de Haan, René J. M. van Zeijl, Inge H. Briaire‐de Bruijn, Gabi W. van Pelt, Anand S. Mehta, Peggy M. Angel, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, Richard R. Drake, Judith V.M.G. Bovée, Liam A. McDonnell, Manfred Wuhrer
2016155
8
N-glycosylation of Colorectal Cancer Tissues
Molecular & Cellular Proteomics ·Crina I.A. Balog, Kathrin Stavenhagen, Wesley L.J. Fung, Carolien A. M. Koeleman, Liam A. McDonnell, Aswin Verhoeven, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, André M. Deelder, Manfred Wuhrer
2012140
9
Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Gabi W. van Pelt, Sanne Kjær‐Frifeldt, J. Han van Krieken, Raed Al Dieri, Hans Morreau, Rob A.�E.�M. Tollenaar, Flemming Brandt Sørensen, Wilma E. Mesker
2018135
10
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
Breast Cancer Research and Treatment ·Tim Dekker, Cornelis J.�H. van de Velde, Gabi W. van Pelt, Judith R. Kroep, JP Julien, Vincent T.H.B.M. Smit, Rob A.�E.�M. Tollenaar, Wilma E. Mesker
2013122
11
Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients.
PubMed ·Wilma E. Mesker, Gerrit‐Jan Liefers, Jan M. C. Junggeburt, Gabi W. van Pelt, Paola Alberici, Peter J.K. Kuppen, Noel F. de Miranda, Karin A. M. van Leeuwen, Hans Morreau, Károly Szuhai, Rob A.�E.�M. Tollenaar, Hans J. Tanke
2009114
12
c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway
Cancer Research ·Yihao Li, Ke Jin, Gabi W. van Pelt, Hans van Dam, Yu Xiao, Wilma E. Mesker, Peter ten Dijke, Fangfang Zhou, Long Zhang
2016108
13
The tumour–stroma ratio in colon cancer: the biological role and its prognostic impact
Histopathology ·Gabi W. van Pelt, Tessa P. Sandberg, Hans Morreau, Hans Gelderblom, J. Han van Krieken, Rob A.�E.�M. Tollenaar, Wilma E. Mesker
2018108
14
Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis
Clinical Cancer Research ·Sijia Liu, Román González‐Prieto, Mengdi Zhang, Paul P. Geurink, Raymond Kooij, Prasanna Vasudevan Iyengar, Maarten van Dinther, Erik Bos, Xiaobing Zhang, Sylvia E. Le Dévédec, Bob van de Water, Roman I. Koning, Hong‐Jian Zhu, Wilma E. Mesker, Alfred C.O. Vertegaal, Huib Ovaa, Long Zhang, John W.M. Martens, Peter ten Dijke
2019108
15
Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer
BMC Cancer ·Tessa P. Sandberg, Maaike P. M. E. Stuart, Jan Oosting, Rob A.�E.�M. Tollenaar, Cornelis F.M. Sier, Wilma E. Mesker
201999
16
Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer
Cellular Oncology ·Oscar Geessink, Alexi Baidoshvili, Joost M. Klaase, Babak Ehteshami Bejnordi, Geert Litjens, Gabi W. van Pelt, Wilma E. Mesker, Irıs D. Nagtegaal, Francesco Ciompi, Jeroen van der Laak
201994
17
Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section
Analytical Chemistry ·Bram Heijs, Stephanie Holst, Inge H. Briaire‐de Bruijn, Gabi W. van Pelt, Arnoud H. de Ru, Peter A. van Veelen, Richard R. Drake, Anand S. Mehta, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, Judith V.M.G. Bovée, Manfred Wuhrer, Liam A. McDonnell
201687
18
Differences between colon and rectal cancer in complications, short-term survival and recurrences
International Journal of Colorectal Disease ·Max P.L. van der Sijp, Esther Bastiaannet, Wilma E. Mesker, Lydia G. van der Geest, A.J. Breugom, Willem H. Steup, Andreas Marinelli, Larissa Tseng, Rob A.�E.�M. Tollenaar, Cornelis J.�H. van de Velde, Jan Willem T. Dekker
201681
19
The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
Breast Cancer Research and Treatment ·Claire J.H. Kramer, Kiki M. H. Vangangelt, Gabi W. van Pelt, Tim Dekker, Rob A.�E.�M. Tollenaar, Wilma E. Mesker
201874
20
N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression
Molecular & Cellular Proteomics ·Stephanie Holst, Anna J.M. Deuss, Gabi W. van Pelt, Sandra J. van Vliet, Juan J. García‐Vallejo, Carolien A. M. Koeleman, André M. Deelder, Wilma E. Mesker, Rob A.�E.�M. Tollenaar, Yoann Rombouts, Manfred Wuhrer
201671

About Wilma E. Mesker

Wilma E. Mesker is a scholar working on Oncology, Molecular Biology, Cancer Research, Spectroscopy and Pathology and Forensic Medicine, having authored 160 papers that have together received 5.6k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (19 papers), Breast Cancer Treatment Studies (19 papers), Colorectal Cancer Surgical Treatments (18 papers), Advanced Proteomics Techniques and Applications (17 papers), Colorectal Cancer Treatments and Studies (11 papers), Colorectal Cancer Screening and Detection (10 papers), Mass Spectrometry Techniques and Applications (10 papers) and Genetic factors in colorectal cancer (10 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (1.0k citations), Molecular Biology (2.0k citations), Pathology and Forensic Medicine (428 citations) and Radiology, Nuclear Medicine and Imaging (545 citations). Wilma E. Mesker has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Rob A.�E.�M. Tollenaar, Gabi W. van Pelt, Hans J. Tanke, Vincent T.H.B.M. Smit, Peter J.K. Kuppen, Tim Dekker, Cornelis J.�H. van de Velde, Manfred Wuhrer, Peter ten Dijke and Hein Putter. Their work appears in journals such as Breast Cancer Research and Treatment, Cytometry, Annals of Oncology, Cellular Oncology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katja SpechtBreakdown of academic impact, for papers by Arne WarthBreakdown of academic impact, for papers by Gustavo BarettonBreakdown of academic impact, for papers by Mark C. KelleyBreakdown of academic impact, for papers by Vincent T.H.B.M. SmitBreakdown of academic impact, for papers by Silvia Darb‐EsfahaniBreakdown of academic impact, for papers by Nam Hoon ChoBreakdown of academic impact, for papers by Elaine W. KayBreakdown of academic impact, for papers by Maarit BärlundBreakdown of academic impact, for papers by Raheela Ashfaq